09.12.12
The Japanese Patent Office has issued Nutraceutix, Redmond, WA, patent number 5041651 for its BIO-tract delivery technology. The Canadian Patent Office has also allowed the company patent application number 2461708, which it expects to formally issue in the coming days. These are the fifth and sixth international patents that the delivery technology has been awarded.
Nutraceutix’s BIO-tract tablets help shield probiotic organisms from the harsh acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets gradually release live organisms at rates determined by formulation. The BIO-tract delivery system is not limited to probiotics, and can be applied to other ingredients that benefit from effective gastric acid protection, buffering, controlled release and once-daily dosing.
Nutraceutix’s BIO-tract tablets help shield probiotic organisms from the harsh acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets gradually release live organisms at rates determined by formulation. The BIO-tract delivery system is not limited to probiotics, and can be applied to other ingredients that benefit from effective gastric acid protection, buffering, controlled release and once-daily dosing.
